The Neurodevelopmental and Behavioral Phenotyping Screening Protocol
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00271622|
Recruitment Status : Recruiting
First Posted : January 2, 2006
Last Update Posted : March 4, 2020
This study will screen children and adolescents (and their parents) to determine the child's eligibility for participation in NIMH research studies on autism spectrum disorders, such as autism and Rett's Disorder.
Screening evaluations include some or all of the following procedures:
Parent and child evaluations including:
- Diagnostic interview
- Developmental or cognitive testing
- Ratings of psychiatric and medical symptoms
- Neuropsychological testing
- Personal, social an family history
Child physical examination and possible blood draw
Children who are determined eligible for a current NIMH research protocol are invited to participate.
|Condition or disease|
|Neurologic Disorders Autism Neurodegenerative Disease Neurobehavioral Manifestation|
|Study Type :||Observational|
|Estimated Enrollment :||5000 participants|
|Official Title:||The Neurodevelopmental and Behavioral Phenotyping Screening Protocol|
|Actual Study Start Date :||December 29, 2005|
individuals with risk for psychiatric disorders or neurodevelo
individuals with risk for psychiatric disorders or neurodevelopmental disorders, such as autism spectrum disorders.
- Screening evaluations such as a psychiatric interview; a diagnostic interview; developmental and/or cognitive testing; ratings of other psychiatric symptoms [ Time Frame: ongoing ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00271622
|Contact: Audrey E Thurm, Ph.D.||(301) firstname.lastname@example.org|
|United States, Maryland|
|National Institutes of Health Clinical Center, 9000 Rockville Pike||Recruiting|
|Bethesda, Maryland, United States, 20892|
|Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR) 800-411-1222 ext TTY8664111010 email@example.com|
|Principal Investigator:||Audrey E Thurm, Ph.D.||National Institute of Mental Health (NIMH)|